How do I treat an elderly patient with low-risk MDS?

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: July 17, 2014
Expiration Date: July 17, 2015

Expected time to complete this activity as designed: 30 minutes
There are no fees for participating in or receiving credit for this online activity.

Program Overview

Myelodysplastic syndromes are a heterogeneous group of diseases that manifest essentially with peripheral cytopenia and a propensity for AML transformation at a rate of approximately 30%. In the bone marrow biopsy and aspirate, the diagnosis of MDS requires bone marrow dysplasia and may be accompanied by elevations in myeloblast count as well as chromosomal and genetic abnormalities. Community oncology practitioners need to recognize that prognostication is the single most important clinical step for your individual patient because it improves on the estimated natural history of your particular MDS patient, and more important, it helps guide a practitioner’s decision in tailoring therapy, and so it allows for a more personalized approach and a more evidence-based approach to treatment and management.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in the management of patients with myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Perform prognostic risk assessments appropriate for patients with MDS
  • Design treatment plans that are tailored to low-risk elderly MDS patients consistent with clinical guideline recommendations

Agenda

How do I treat an elderly patient with low-risk MDS? – Eric Padron, MD

Instructions for Participation and Credit

This activity is eligible for credit through July 17, 2015. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates may be printed immediately after successfully completing the post-test and activity evaluation.

Faculty Biography

Eric Padron, MD
Assistant Member
Immunology and Malignant Hematology Programs
H. Lee Moffitt Cancer Center and Research Institute
Assistant Professor
Department of Oncologic Sciences
College of Medicine
University of South Florida
Tampa, Florida

Dr. Eric Padron received his medical degree from the University of Florida College of Medicine. He completed his internal medicine residency at University of Florida Shands Hospital, and his hematology/oncology fellowship at Moffitt Cancer Center, University of South Florida. He is currently an assistant member, immunology and malignant hematology programs at H. Lee Moffitt Cancer Center and Research Institute, and is an assistant professor, Department of Oncologic Sciences, College of Medicine, University of South Florida.

Dr. Padron is board certified in internal medicine and oncology, board eligible in hematology, and holds memberships in the American Society of Hematology, American Society of Clinical Oncology, and the American Association of Cancer Research. He is a journal reviewer for Future Medicine, Blood, Leukemia Research, Leukemia, Therapeutic Advances in Hematology, Blood Cancer Journal, American Journal of Hematology, and OncoTargets and Therapy. His clinical interests are the care and treatment of patients with adult myeloid malignancies including MDS, AML and myeloproliferative neoplasms (MPNs) with a specific interest in the myeloproliferative/myelodysplastic (MDS/MPN) syndromes.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for .5 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-14-013-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when registering for a CPE program. Please make sure to provide this information in your Member Profile accessed through the Member Center on the home page of this site.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Eric Padron has disclosed no relevant financial relationships.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, and Eugene R. Tombler, PhD, FACME, medical director, oncology, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is independently peer reviewed for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Padron has indicated that he does intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US.

Dr. Padron has indicated that he does intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.

Hardware/Software/Internet Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 9.0 or higher, the latest version of Google Chrome, or the latest version of Safari, a computer running Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may include Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player, and/or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at info@managingmds.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2014 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved